LIDDS
0.05 SEK
-12.94 %
Less than 1K followers
LIDDS
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-12.94 %
-16.16 %
-17.55 %
+24.50 %
-50.94 %
-54.73 %
-98.35 %
-99.62 %
-99.48 %
LIDDS is a pharmaceutical company. The company develops pharmaceutical products based on a patented and clinically tested drug delivery technology. The properties of the products form the basis of the LIDDS technology platform for the development of injectable pharmaceutical products. LIDDS is the abbreviation for Local Intelligent Drug Delivery System, and the company is headquartered in Uppsala.
Read moreMarket cap
6.8M SEK
Turnover
2.95K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
18/12
2025
Extraordinary general meeting '25
19/2
2026
Annual report '25
28/5
2026
Interim report Q1'26
All
Press releases
ShowingAll content types
Change of Certified Adviser (CA) to G&W Fondkommission
LIDDS AB (publ) har ingått avtal om omvänt förvärv av Proport Invest AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools